Loading
Latest filing published 30 Mar 2022 for Aarti Drugs Limited, €631k.
Rashesh Chandrakant Gogri (chief executive) discloses dealings in Aarti Drugs Limited to SEBI (PIT + SAST). Between 18 May 2021 and 28 March 2022, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 1 purchase worth €631k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2022 alone, the filings show 1 purchase and no sales.
Most recently, on 30 March 2022, the filings show an open-market purchase worth €631k in Aarti Drugs Limited. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations